UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-009-0683-8PMID 20037778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications

  2009cited by this paper
• UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells

  2008cited by this paper
• The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression

  2008cited by this paper
• The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA

  2007cited by this paper
• UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells

  2007cited by this paper
• Influence of cytokines onmdr1 expression in human colon carcinoma cell lines: Increased cytoxicity of MDR relevant drugs

  2005cited by this paper
• ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain

  2004cited by this paper
• CBP and p300: versatile coregulators with important roles in hematopoietic gene expression

  2002cited by this paper
• CREB-binding Protein and p300 in Transcriptional Regulation*

  2001cited by this paper
• ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.

  2000cited by this paper
• Transcriptional Activation of the MDR1 Gene by UV Irradiation

  2000cited by this paper
• Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.

  1999cited by this paper
• A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.

  1998cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1998cited by this paper
• Transcriptional Regulation of the MDR1 Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-Y

  1998cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1997cited by this paper
• Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.

  1996cited by this paper
• The CBP co-activator is a histone acetyltransferase

  1996cited by this paper
• The P-glycoprotein multidrug transporter.

  1996cited by this paper
• Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.

  1996cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.

  1993cited by this paper
• Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.

  1993cited by this paper
• Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.

  1990cited by this paper
• Multidrug Resistance and P‐Glycoprotein Expression

  1987cited by this paper
• Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

  1986cited by this paper
• Reduced permeability in CHO cells as a mechanism of resistance to colchicine

  1974cited by this paper

• Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA

  2023cites this paper
• Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors.

  2022cites this paper
• Long non-coding RNA PCDRlnc1 confers docetaxel resistance in prostate cancer by promoting autophagy

  2022cites this paper
• Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way

  2021cites this paper
• Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention

  2020cites this paper
• ROLE OF UHRF1 IN MALIGNANCY AND ITS FUNCTION AS A THERAPEUTIC TARGET FOR MOLECULAR DOCKING TOWARDS THE SRA DOMAIN.

  2019cites this paper
• Overexpression of UHRF1 and its potential role in the development of invasive ductal breast cancer validated by integrative bioinformatics and immunohistochemistry analyses

  2019cites this paper
• DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications

  2019cites this paper
• Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates

  2019cites this paper
• An Intramolecular Interaction of UHRF1 Reveals Dual Control for Its Histone Association.

  2018cites this paper
• Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions*

  2018cites this paper
• PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

  2018cites this paper
• FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

  2018cites this paper
• Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription

  2018cites this paper
• UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter.

  2017cites this paper
• Epigenetic regulation of drug transporter expression in human tissues

  2017cites this paper
• TAT-Modified Gold Nanoparticle Carrier with Enhanced Anticancer Activity and Size Effect on Overcoming Multidrug Resistance.

  2017cites this paper
• The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells

  2017cites this paper
• Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma.

  2015cites this paper
• Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

  2015cites this paper
• Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.

  2015cites this paper
• Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance

  2015cites this paper
• Cancer Stem Cells and Chemoresistance: Strategies to Overcome Therapeutic Resistance

  2015cites this paper
• Transcriptome analysis of adult neural stem cells and functional analysis of the candidate genes TSP-4 and Uhrf1

  2014cites this paper
• Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells

  2014cites this paper
• Tumorigenic and Angiogenic Response to Loop Regulates the Invasion and miR-326-Histone Deacetylase-3 Feedback Cell

  2014cites this paper
• miR-326-Histone Deacetylase-3 Feedback Loop Regulates the Invasion and Tumorigenic and Angiogenic Response to Anti-cancer Drugs*

  2014cites this paper
• ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo.

  2014cites this paper
• Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of action.

  2013cites this paper
• Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.

  2013cites this paper
• Diagnostic and prognostic value of plasma and tissue ubiquitin‐like, containing PHD and RING finger domains 1 in breast cancer patients

  2013cites this paper
• Elevated level of lysine 9‐acetylated histone H3 at the MDR1 promoter in multidrug‐resistant cells

  2012cites this paper
• Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo

  2012cites this paper
• UHRF1 is a Potential Molecular Marker for Diagnosis and Prognosis of Bladder Cancer

  2012cites this paper
• Involvement of V-Ets erythroblastosis virus E26 oncogene homolog 2 in regulation of transcription activity of MDR1 gene.

  2012cites this paper
• 24 Breast Cancer Stem Cells – A Review

  2012cites this paper
• Inhibition Effect of siRNA-Downregulated UHRF1 on Breast Cancer Growth

  2011cites this paper
• Breast Cancer Stem Cells – A Review

  2011cites this paper
• The Roles of the Methyl-CpG Binding Proteins in Cancer.

  2011cites this paper
• MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research

  2011cites this paper
• Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene.

  2010cites this paper
• UHRF1 is a genome caretaker that facilitates the DNA damage response to γ-irradiation

  2010cites this paper